GATA6 identifies an immune-enriched phenotype linked to favorable outcomes in patients with pancreatic cancer undergoing upfront surgery
This study underscores GATA6's role in distinguishing classical and basal-like pancreatic ductal adenocarcinoma (PDAC) phenotypes. Retrospective studies associate GATA6 immunohistochemistry (IHC) expression with survival outcomes, warranting prospective validation. In a prospective treatment-na...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | 英語 |
| 出版事項: |
2024
|
| オンライン･アクセス: | https://doi.org/10.1016/j.xcrm.2024.101557 https://www.cell.com/article/S2666379124002490/pdf |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|